Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Inflammatory Bowel Diseases

Free Subscription 19.01.2026 1 AJR Am J Roentgenol 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 3 BMC Gastroenterol 2 Clin Gastroenterol Hepatol 1 Clin Res Hepatol Gastroenterol 2 Dig Dis Sci 1 Dis Colon Rectum 2 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 3 Inflamm Bowel Dis 2 J Clin Gastroenterol 1 J Crohns Colitis 2 J Gastroenterol 3 Lancet Gastroenterol Hepatol 1 PLoS One 1 Scand J Gastroenterol 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. GEE MS
   Probable Stricture Is an Important Imaging Biomarker in Small Bowel Crohn Disease.
   AJR Am J Roentgenol. 2026 Jan 14. doi: 10.2214/AJR.25.34496.
   PubMed        
   
   

   
   Aliment Pharmacol Ther

2. ALSAKARNEH S, Tome J, Farraye FA, Pardi DS, et al
   Research Communication: Comparative Effectiveness of Ustekinumab and Vedolizumab in the Management of Chronic Pouchitis-A Population-Based Study.
   Aliment Pharmacol Ther. 2026;63:424-428.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

3. SHAH ND
   Continuing Medical Education Questions: February 2025.
   Am J Gastroenterol. 2025;120:289.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. HUANG M, Luo Q, Huang S, Zheng Y, et al
   Shared and distinct spontaneous brain activity pattern in crohn's disease and ulcerative colitis: evidence from cortical surface?based analysis.
   BMC Gastroenterol. 2026 Jan 16. doi: 10.1186/s12876-026-04615.
   PubMed         Abstract available
   
   
5. ABHARI AP, Rezvanian P, Sohrabi E, Hosseini K, et al
   Targeted therapies and their outcomes in monogenic very early onset inflammatory bowel disease: a systematic review.
   BMC Gastroenterol. 2026 Jan 16. doi: 10.1186/s12876-025-04592.
   PubMed        
   
   
6. WANG H, Shao R, Wu S, Zhu Y, et al
   The value of platelet-associated parameters as biomarkers in evaluating the disease activity of inflammatory bowel disease: a systematic review and meta-analysis.
   BMC Gastroenterol. 2026 Jan 13. doi: 10.1186/s12876-026-04603.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

7. KOCHHAR GS, Coelho-Prabhu N, Hashash JG, Shen B, et al
   AGA Clinical Practice Update on the Role of Therapeutic Endoscopy in Inflammatory Bowel Disease: Commentary.
   Clin Gastroenterol Hepatol. 2026 Jan 9:S1542-3565(25)00990.
   PubMed         Abstract available
   
   
8. WU RY, Xue M, Zhao Q, Jeong S, et al
   Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn's Disease in First-Degree Relatives.
   Clin Gastroenterol Hepatol. 2026 Jan 12:S1542-3565(25)01031.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

9. SCOTTI GB, Zullo F, Mattana M, Covotta F, et al
   Fecal calprotectin in patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2026 Jan 13:102764.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

10. HOLTEN KIA, Bernklev T, Opheim R, Olsen BC, et al
    Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III study.
    Dig Dis Sci. 2026 Jan 12. doi: 10.1007/s10620-025-09661.
    PubMed         Abstract available
    
    
11. MOHAMED MFH, Gupta SR, Beran A, Hamid O, et al
    Pneumococcal Vaccine Is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights from a Propensity-Matched Study in the United States.
    Dig Dis Sci. 2026 Jan 10. doi: 10.1007/s10620-025-09653.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

12. HERMANSON M, Park JJ, Brar MS, de Buck van Overstraeten A, et al
    Patient Preferences for Vaginal Delivery Versus Cesarean Section After IPAA.
    Dis Colon Rectum. 2026;69:201-208.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

13. NATHA C, Colli Cruz C, Vemulapalli V, Sullivan A, et al
    Risk factors and clinical course of inflammatory bowel disease in patients receiving cancer therapy.
    Eur J Gastroenterol Hepatol. 2026 Jan 6. doi: 10.1097/MEG.0000000000003124.
    PubMed         Abstract available
    
    
14. TANG L, Mo J, Ouyang J, Li W, et al
    A multilevel analysis of the genetic association between inflammatory bowel disease and primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2025 Dec 9. doi: 10.1097/MEG.0000000000003116.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

15. BALDERRAMO D, Montero J, Lasa J, Sueiro RG, et al
    The Argentinian Crohn's Disease and Ulcerative Colitis Registry (RADECCU): methodological aspects and objectives.
    Gastroenterol Hepatol. 2026 Jan 9:502652. doi: 10.1016/j.gastrohep.2026.502652.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

16. VERBURGT CM, Dunn KA, Bielawski JP, Otley AR, et al
    Timing is Everything: Lessons Learned for Building Microbiome-Based Models in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2026 Jan 11:izaf313. doi: 10.1093.
    PubMed        
    
    
17. JONES ASK, Seaton N, Harding S, Duff A, et al
    A Real-World Longitudinal Case-Study Implementing Digital Screening and Treatment for Distress in Inflammatory Bowel Disease: The COMPASS-IBD Patient Journey.
    Inflamm Bowel Dis. 2026 Jan 13:izaf259. doi: 10.1093.
    PubMed         Abstract available
    
    
18. GAN X, Zhang Y, Zhang Y, Ye Z, et al
    Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2026 Jan 16:izaf325. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Gastroenterol

19. ISHIDA N, Tani S, Takebe T, Takahashi K, et al
    Role of Sepsis Markers as Potential Biomarkers for Inflammatory Bowel Disease: A Prospective Observational Study.
    J Clin Gastroenterol. 2025 Aug 11. doi: 10.1097/MCG.0000000000002236.
    PubMed         Abstract available
    
    
20. NJEIM R, Moussa E, Sohail A, Wei C, et al
    Metabolic Comorbidities and Hospital Outcomes in Patients With Inflammatory Bowel Disease: A Nationwide Analysis.
    J Clin Gastroenterol. 2026 Jan 13. doi: 10.1097/MCG.0000000000002333.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

21. CHENG S, Cheng C, Huang C, Liu C, et al
    Intermittent ketogenic diet promotes Treg differentiation and alleviates Crohn's disease via the beta-hydroxybutyrate driven AHCY-DNMT1-Foxp3 axis.
    J Crohns Colitis. 2026 Jan 12:jjag003. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

22. FUJIOKA S, Umeno J, Takeda T, Kinjo K, et al
    Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan.
    J Gastroenterol. 2026 Jan 16. doi: 10.1007/s00535-025-02333.
    PubMed         Abstract available
    
    
23. FUKUI S, Kishimoto M, Matsuura M, Sakamoto A, et al
    Prevalence, characteristics, and screening of spondyloarthritis in Japanese patients with early inflammatory bowel diseases: a prospective multidisciplinary study.
    J Gastroenterol. 2026;61:46-58.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

24. LONG M, Allegretti JR, Danese S, Germinaro M, et al
    Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial.
    Lancet Gastroenterol Hepatol. 2026 Jan 13:S2468-1253(25)00322.
    PubMed         Abstract available
    
    
25. CONLEY S, Kamp KJ, Kane SV
    Menopause and inflammatory bowel disease: more questions than answers.
    Lancet Gastroenterol Hepatol. 2026 Jan 13:S2468-1253(25)00368.
    PubMed        
    
    
26. COHEN NA, Bettenworth D, Sror N, Khedraki R, et al
    Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study.
    Lancet Gastroenterol Hepatol. 2026 Jan 8:S2468-1253(25)00347.
    PubMed         Abstract available
    
    

    
    PLoS One

27. VARGAS-ROBLES D, Yap YR, Singha B, Tien J, et al
    Association of vaginal IL-4, IL-6, IL-8, IL-17, IFN-gamma, and dietary intake with IBD status and vaginal microbiota in pregnant individuals.
    PLoS One. 2026;21:e0335178.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

28. MATTHEWS T, Connor SM, Tyrrell H, Wilson R, et al
    Inpatient and post-discharge thromboembolic events in inflammatory bowel disease patients: a 13 year retrospective cohort study at a tertiary Centre.
    Scand J Gastroenterol. 2026 Jan 13:1-9. doi: 10.1080/00365521.2026.2615394.
    PubMed         Abstract available
    
    

    
    Z Gastroenterol

29. POKRYSZKA J, Primas C, Stadlmann M, Gerold N, et al
    Post-induction serum vedolizumab levels are not associated with better maintenance outcomes in patients with Crohn's disease.
    Z Gastroenterol. 2026 Jan 12. doi: 10.1055/a-2744-5136.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.